Profile picture

Doctor Shira Burg

Tel Aviv University, Tel Aviv (Israel)
Follow
Logo ESC

Contributor content

BA6b9, a novel sk4 K + channel blocker, attenuates atrial fibrillation substrate in rats with reduced ejection fraction
Journal
BA6b9, a novel sk4 K + channel blocker, attenuates atrial fibrillation substrate in rats with reduced ejection fraction
28 October 2024
Read more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources